Department of Pharmacology and Chemical Biology
rAAV vectors
These studies are supported by a suite of biotherapeutic molecules encoded in rAAV vectors.
Multiple mechanisms underlie the degenerative symptomatic phase of a neurodegenertive disease. Will targeting any one pathway ever be effective enough to have a real impact on patient trajectory?
rAAV Delivery

Treatment resistant cancers are rarely treated effectively  with a monotherapy, but a combination therapy delivered  systemically is often too toxic. What about rAAV-mediated local delivery of  a combination of biotherapeutics?

Key Collaborators: Dr. Barbara Osborne U Mass Amherst, Dr. Lucio Miele LSU